{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:49:01Z","timestamp":1767142141066,"version":"build-2238731810"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11845-021-02660-w","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T05:02:47Z","timestamp":1625806967000},"page":"1053-1058","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A cross-section observational study on the seroprevalence of antibodies to COVID-19 in patients receiving opiate agonist treatment"],"prefix":"10.1007","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6187-974X","authenticated-orcid":false,"given":"Fiona","family":"Fenton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siobhan","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Eagleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"key":"2660_CR1","doi-asserted-by":"crossref","unstructured":"Dubey M, Ghosh R, Chatterjee S et al (2020) COVID-19 and addiction","DOI":"10.1016\/j.dsx.2020.06.008"},{"issue":"11","key":"2660_CR2","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1080\/10826084.2020.1791184","volume":"55","author":"J Schimmel","year":"2020","unstructured":"Schimmel J, Manini A (2020) Opioid use disorder and COVID-19: biological plausibility for worsened outcomes. Subst Use Misuse 55(11):1900\u20131901","journal-title":"Subst Use Misuse"},{"issue":"1","key":"2660_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.7326\/M20-1212","volume":"173","author":"N Volkow","year":"2020","unstructured":"Volkow N (2020) Collision of the COVID-19 and addiction epidemics. Ann Intern Med 173(1):61\u201362","journal-title":"Ann Intern Med"},{"key":"2660_CR4","doi-asserted-by":"publisher","unstructured":"Wang Q, Kaelber D, Xu R, Volkow N (2020) COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry.\u00a0https:\/\/doi.org\/10.1038\/s41380-020-00880-7","DOI":"10.1038\/s41380-020-00880-7"},{"key":"2660_CR5","doi-asserted-by":"crossref","unstructured":"Ataei M, Shirazi F, Lamarine R et al (2020) A double-edged sword of using opioids and COVID-19: a toxicological view","DOI":"10.1186\/s13011-020-00333-y"},{"issue":"4","key":"2660_CR6","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1016\/j.bja.2020.07.004","volume":"125","author":"D Lambert","year":"2020","unstructured":"Lambert D (2020) Opioids and the COVID-19 pandemic: does chronic opioid use or misuse increase clinical vulnerability? Br J Anaesth 125(4):e382\u2013e383","journal-title":"Br J Anaesth"},{"key":"2660_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2020.11.027","author":"M Eagleton","year":"2020","unstructured":"Eagleton M, Stokes S, Fenton F, Keenan E (2020) Does opioid substitution treatment have a protective effect on the clinical manifestations of COVID-19? Comment on Br J Anaesth. https:\/\/doi.org\/10.1016\/j.bja.2020.11.027","journal-title":"Comment on Br J Anaesth"},{"key":"2660_CR8","unstructured":"EMCDDA\u00a0(2020) [Internet]. Emcdda.europa.eu.  [cited 12 November 2020]. Available from: https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/13073\/EMCDDA-Trendspotter-Covid-19_Wave-1-2.pdf"},{"key":"2660_CR9","doi-asserted-by":"publisher","first-page":"108302","DOI":"10.1016\/j.drugalcdep.2020.108302","volume":"217","author":"G Welle-Strand","year":"2020","unstructured":"Welle-Strand G, Skurtveit S, Clausen T et al (2020) COVID-19 survey among people who use drugs in three cities in Norway. Drug Alcohol Depend 217:108302","journal-title":"Drug Alcohol Depend"},{"key":"2660_CR10","doi-asserted-by":"crossref","unstructured":"Vallecillo G, Perell\u00f3 R, G\u00fcerri R et al (2020) Clinical impact of COVID-19 on people with substance use disorders. J Public Health","DOI":"10.1093\/pubmed\/fdaa181"},{"key":"2660_CR11","doi-asserted-by":"crossref","unstructured":"Yao H, Chen J, Xu Y (2020) Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry 7(4):e21","DOI":"10.1016\/S2215-0366(20)30090-0"},{"issue":"3","key":"2660_CR12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1124\/jpet.120.000170","volume":"375","author":"A Sifat","year":"2020","unstructured":"Sifat A, Nozohouri S, Villalba H et al (2020) The role of smoking and nicotine in the transmission and pathogenesis of COVID-19. J Pharmacol Exp Ther 375(3):498\u2013509","journal-title":"J Pharmacol Exp Ther"},{"key":"2660_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/path.5471","author":"AR Bourgonje","year":"2019","unstructured":"Bourgonje AR, Abdulle AE, Timens W et al (2019) Angiotensin-converting enzyme-2 (ACE2), SARS-CoV-2 and pathophysiology of coronavirus disease (COVID-19). Journal of Pathology, Invited Review. https:\/\/doi.org\/10.1002\/path.5471","journal-title":"Journal of Pathology, Invited Review"},{"key":"2660_CR14","unstructured":"https:\/\/www.hpsc.ie\/a-z\/respiratory\/coronavirus\/novelcoronavirus\/casesinireland\/epidemiologyofcovid-19inireland\/october2020\/COVID-19_Daily_epidemiology_report_(NPHET)_20201030%20-%20website.pdf. Accessed 16 April 2021"},{"key":"2660_CR15","unstructured":"Study to investigate COVID-19 infection in people living in Ireland (SCOPI) (2020) Journal of Pathology, Invited  [Internet]. Hpsc.ie.\u00a0[cited 21 November 2020]. Available from: https:\/\/www.hpsc.ie\/a-z\/respiratory\/coronavirus\/novelcoronavirus\/scopi\/SCOPI%20report%20preliminary%20results%20final%20version.pdf"},{"key":"2660_CR16","unstructured":"https:\/\/www.hpsc.ie\/a-z\/respiratory\/coronavirus\/novelcoronavirus\/casesinireland\/epidemiologyofcovid-19inireland\/july2020\/COVID-19_Daily_epidemiology_report_(NPHET)_31072020%20-%20Website.pdf. Accessed 16 April 2021"},{"key":"2660_CR17","unstructured":"IOTOD annual-conference 24\u201325 September 2020 Dr Stephan Walcher Director, Concept Centre for Addiction Medicine, Munich, Germany"}],"updated-by":[{"DOI":"10.1007\/s11845-021-02742-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000}}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-021-02660-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-021-02660-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-021-02660-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T11:20:50Z","timestamp":1653650450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-021-02660-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["2660"],"URL":"https:\/\/doi.org\/10.1007\/s11845-021-02660-w","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]},"assertion":[{"value":"23 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11845-021-02742-9","URL":"https:\/\/doi.org\/10.1007\/s11845-021-02742-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}